What is Trump Rx? How to access lowest drug prices in the US? Explained

President Trump has launched TrumpRx.gov to reduce prescription drug costs, claiming price cuts of 400% to 600% by January 2026.

Updated on: Dec 20, 2025, 01:42:24 IST

By Prakriti Deb

Prefer HTon Google

Share via

Copy link

President Donald Trump has announced a new initiative aimed at lowering prescription drug costs, unveiling TrumpRx.gov, a website he says will offer Americans access to sharply reduced drug prices beginning in January 2026.

TrumpRx.gov signage in the Oval Office of the White House in Washington, DC. (Bloomberg)

The announcement came during a White House press conference, where Trump said he had negotiated directly with pharmaceutical companies and foreign governments to secure dramatic price reductions. “I’m doing what no politician of either party has ever done–standing up to the special interests to dramatically reduce the price of prescription drugs,” Trump said.

What is TrumpRx.gov?

TrumpRx.gov is described by the president as a central portal where Americans will be able to purchase or access prescription medications at significantly lower prices.

While the site is not yet operational, it currently displays the message: “Coming soon. January 2026”

Also Read: Trump drug price announcement: List of 9 companies under new sweep of Most Favored Nation program

Trump said the first wave of drug price cuts would be rolled out through the platform, with reductions ranging from 400% to 600%.

How would it lower drug prices?

Trump argues that his plan bypasses what he calls inflated pricing structures maintained by insurers and middlemen. In his remarks, he accused health insurance companies of “getting rich on billions of dollars of money that should go directly to the people.”

He also criticized the Affordable Care Act (ACA), calling it “unaffordable” and claiming it was designed to benefit insurance companies.

The announcement comes as millions of Americans who rely on ACA marketplace plans face sharp premium increases next year, PBS NewsHour reported. According to the report, average premiums are expected to roughly double after Congress failed to reach an agreement on extending enhanced subsidies set to expire at the end of the month.

ABOUT THE AUTHOR
Prakriti Deb
Prakriti Deb is a journalist at Hindustan Times Digital, where she is part of the US Desk. She works on stories related to American politics, crime, sports, entertainment and weather. She particularly enjoys covering political developments that have global ripples. Through her work, she aims to break down complex events in a way that feels simple and understandable. Before joining the Hindustan Times, she worked with The Indian Express Digital, where she covered world affairs. She holds a postgraduate degree in Mass Communication with a specialisation in Journalism, along with a bachelor’s degree in English Literature. Outside the newsroom, Prakriti enjoys travelling and stepping out of her comfort zone. She finds her sense of being through storytelling in all its forms, including conversations, painting, theatre, dance and photography. She appreciates discussions that challenge her perspective and help her see the world a little differently.Read More

Stay updated with US News covering politics, crime, weather, local events, and sports highlights. Get the latest on Donald Trump and American politics along with Horoscope 2026.